(function(doc, html, url) { var widget = doc.createElement("div"); widget.innerHTML = html; var script = doc.currentScript; // e = a.currentScript; if (!script) { var scripts = doc.scripts; for (var i = 0; i < scripts.length; ++i) { script = scripts[i]; if (script.src && script.src.indexOf(url) != -1) break; } } script.parentElement.replaceChild(widget, script); }(document, '

CNIH4 is a diagnostic and prognostic biomarker for HNSC patients.

What is it about?

The diagnosis and prognosis of neck squamous cell carcinoma (HNSC) is a challenge for clinical HNSC management, thus, the investigation of molecular biomarkers of HNSC is urgent.

Why is it important?

The diagnosis and prognosis of neck squamous cell carcinoma (HNSC) is a challenge for clinical HNSC management, thus, the investigation of molecular biomarkers of HNSC is urgent. We analyzed mRNA seq data, protein staining data, and single-cell expression data of HNSC from open databases and evaluated the diagnostic and prognostic value of CNIH4, and investigated the association of CNIH4 to HNSC cancer biology and immunity. This study demonstrated that CNIH4 is a diagnostic and prognostic biomarker for HNSC patients and can potentially affect the cancer stemness and tumor immune microenvironment of HNSC cells.

Read more on Kudos…
The following have contributed to this page:
Hengrui Liu
' ,"url"));